by Adrienne Williamson , Medical Xpress HLA-I hyperexpression is present in the islets of double AAb+ and T1D donors. (A and C) Representative immunofluorescence images from islets (A) and exocrine tissue (C) showing normal (top), elevated (middle), and hyperexpression (bottom) of HLA-I. The right panels display heatmaps based on the relative fluorescence intensity unit of...
Category: <span>Diabetes</span>
Study shows that regular physical activity is an effective strategy to prevent type 2 diabetes
by Diabetologia Credit: Unsplash/CC0 Public Domain New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) shows that regular physical activity is a safe diabetes prevention strategy for people residing in relatively polluted regions. The study, which is the first to investigate the combined effects of physical activity and pollution exposure on type 2 diabetes risk, is...
Women with type 1 diabetes experience a shorter reproductive period
THE NORTH AMERICAN MENOPAUSE SOCIETY (NAMS) CLEVELAND, Ohio (March 3, 2021)–The length of the female reproductive period (the time from the onset of menses to the final menstrual period) has important health implications. A new study compared the length of reproductive periods for women with type 1 diabetes with women without diabetes to confirm the...
Aggressive intervention recommended to prevent pediatric diabetes
by American Osteopathic Association Credit: Unsplash/CC0 Public Domain Type 2 diabetes, once considered an adult disease, is increasingly causing health complications among American youth. A research review published in the Journal of Osteopathic Medicine suggests physicians should work to more aggressively prevent pediatric diabetes. Because few pediatric Type 2 diabetes treatment options are available, prevention is unusually...
Birthweight strongly linked to type 2 diabetes risk in adulthood
by British Medical Journal Credit: CC0 Public Domain A birthweight of 2.5 kg or more is strongly linked to the risk of developing type 2 diabetes in adulthood, finds research published in the online journal BMJ Open Diabetes Research & Care. It is associated with lower circulating levels of insulin-like growth factor-1, or IGF-1 for short, a...
Could transforming alpha cells into beta cells treat diabetes?
New research in mice suggests a novel way to treat both forms of diabetes. 1130945222 Tom Werner/Getty Images Scientists have used synthetic antibodies to block cell receptors in the liver that normally bind to glucagon, a hormone involved in increasing the amount of glucose in the blood. The antibodies restored normal blood glucose levels in three different...
Weight loss drug hope for patients with type 2 diabetes
by University of Leicester Credit: Unsplash/CC0 Public Domain Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10 kg, according to a new study published in The Lancet today. Led by Melanie Davies, Professor of Diabetes Medicine at...
Artificial pancreas system upgraded with AI algorithm
POHANG UNIVERSITY OF SCIENCE & TECHNOLOGY (POSTECH) IMAGE: FULLY AUTOMATED PANCREAS SYSTEM USING AI: AI ALGORITHM USED TO FULLY AUTOMATE INSULIN INJECTION BY ADDING A PHARMACOLOGICAL CONCEPT TO REINFORCEMENT LEARNING CREDIT: POSTECH Diabetes is on the rise worldwide. It is a permanent condition that requires care over a life time. To help manage it, an...
Experimental treatment appears to subdue type 1 diabetes in laboratory mice
by University of Utah Health Sciences Credit: Unsplash/CC0 Public Domain An experimental treatment can essentially reverse type 1 diabetes in certain types of laboratory mice, according to a series of studies led by University of Utah Health scientists. An injection of the therapeutic agent converts cells that normally control glucose production into ones that generate insulin....
Placental Allografts for Diabetic Foot Ulcers
FEBRUARY 18TH, 2021 CONN HASTINGS EXCLUSIVE, MEDICINE, SURGERY, VASCULAR SURGERY MiMedx, a medtech company based in Georgia, has developed EpiFix, an off-the-shelf allograft system for the treatment of diabetic foot ulcers. The grafts are made using donated human placental tissues that are obtained from consenting mothers during caesarean section procedures. The tissues then undergo a proprietary processing...